海思科：聚普瑞锌颗粒通过仿制药一致性评价

array(1) { [391308]=> array(2) { [2]=> array(4) { [0]=> string(6) "药品" [1]=> string(15) "一致性评价" [2]=> string(9) "仿制药" [3]=> string(9) "海思科" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }